These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 1959370
1. Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis. Davies SP, Reaveley DA, Brown EA, Kox WJ. Crit Care Med; 1991 Dec; 19(12):1510-5. PubMed ID: 1959370 [Abstract] [Full Text] [Related]
2. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE. Crit Care Med; 2000 Apr; 28(4):1161-5. PubMed ID: 10809299 [Abstract] [Full Text] [Related]
3. Amino acid losses during hemodialysis: effects of high-solute flux and parenteral nutrition in acute renal failure. Hynote ED, McCamish MA, Depner TA, Davis PA. JPEN J Parenter Enteral Nutr; 1995 Apr; 19(1):15-21. PubMed ID: 7658594 [Abstract] [Full Text] [Related]
4. Amino acid losses during sustained low efficiency dialysis in critically ill patients with acute kidney injury. Umber A, Wolley MJ, Golper TA, Shaver MJ, Marshall MR. Clin Nephrol; 2014 Feb; 81(2):93-9. PubMed ID: 24290407 [Abstract] [Full Text] [Related]
5. Techniques of continuous arteriovenous hemofiltration and hemodialysis. Renal replacement in the ICU for hypervolemic, uremic patients. Merrill RH. J Crit Illn; 1991 Apr; 6(4):381-7. PubMed ID: 10147916 [Abstract] [Full Text] [Related]
6. Treatment of acute renal failure in an infant by continuous arteriovenous hemodialysis. Assadi FK. Pediatr Nephrol; 1988 Jul; 2(3):320-2. PubMed ID: 3153035 [Abstract] [Full Text] [Related]
7. Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis. Bonnardeaux A, Pichette V, Ouimet D, Geadah D, Habel F, Cardinal J. Am J Kidney Dis; 1992 Jan; 19(1):31-8. PubMed ID: 1739079 [Abstract] [Full Text] [Related]
8. Continuous arteriovenous haemodiafiltration in the critically ill: influence on major nutrient balances. Bellomo R, Martin H, Parkin G, Love J, Kearley Y, Boyce N. Intensive Care Med; 1991 Jan; 17(7):399-402. PubMed ID: 1774393 [Abstract] [Full Text] [Related]
9. Gentamicin clearance during continuous arteriovenous hemodiafiltration. Ernest D, Cutler DJ. Crit Care Med; 1992 May; 20(5):586-9. PubMed ID: 1572182 [Abstract] [Full Text] [Related]
10. Amino acid balance with extended daily diafiltration in acute kidney injury. Chua HR, Baldwin I, Fealy N, Naka T, Bellomo R. Blood Purif; 2012 May; 33(4):292-9. PubMed ID: 22652535 [Abstract] [Full Text] [Related]
11. "Machineless" nutritional hemodialysis. Roberts M, Barney MH, Trott MA, Montez AJ, Stephens VM, Lee DB. ASAIO Trans; 1989 May; 35(3):270-3. PubMed ID: 2512967 [Abstract] [Full Text] [Related]
12. Solute transport in continuous hemodialysis: a new treatment for acute renal failure. Sigler MH, Teehan BP. Kidney Int; 1987 Oct; 32(4):562-71. PubMed ID: 3430952 [Abstract] [Full Text] [Related]
13. High dialysate flow rate continuous arteriovenous hemodialysis: a new approach for the treatment of acute renal failure and tumor lysis syndrome. Pichette V, Leblanc M, Bonnardeaux A, Ouimet D, Geadah D, Cardinal J. Am J Kidney Dis; 1994 Apr; 23(4):591-6. PubMed ID: 8154498 [Abstract] [Full Text] [Related]
14. Amino acid losses and nitrogen balance during slow diurnal hemodialysis in critically ill patients with renal failure. Kihara M, Ikeda Y, Fujita H, Miura M, Masumori S, Tamura K, Yabana M, Takagi N, Umemura S, Ishii M. Intensive Care Med; 1997 Jan; 23(1):110-3. PubMed ID: 9037649 [Abstract] [Full Text] [Related]
15. Effect of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure. Bellomo R, McGrath B, Boyce N. Crit Care Med; 1994 May; 22(5):833-7. PubMed ID: 8181293 [Abstract] [Full Text] [Related]
16. Removal characteristics and total dialysate content of glutamine and other amino acids in critically ill patients with acute kidney injury undergoing extended dialysis. Schmidt JJ, Hafer C, Spielmann J, Hadem J, Schönenberger E, Schmidt BM, Kielstein JT. Nephron Clin Pract; 2014 May; 126(1):62-6. PubMed ID: 24577340 [Abstract] [Full Text] [Related]
17. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure. Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Parenti E, Picetti E, Sagripanti S, Manini P, Andreoli R, Cabassi A. Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148 [Abstract] [Full Text] [Related]
18. Clearance of imipenem/cilastatin in acute renal failure patients treated by continuous hemodiafiltration (CAVHD). Vos MC, Vincent HH, Yzerman EP. Intensive Care Med; 1992 Dec; 18(5):282-5. PubMed ID: 1527259 [Abstract] [Full Text] [Related]
19. Continuous arteriovenous hemodialysis: outcome in intensive care acute renal failure patients. Alarabi AA, Danielson BG, Wikström B. Nephron; 1993 Dec; 64(1):58-62. PubMed ID: 8502337 [Abstract] [Full Text] [Related]
20. Removal of branched-chain amino acids by peritoneal dialysis, continuous arteriovenous hemofiltration, and continuous arteriovenous hemodialysis in rabbits: implications for maple syrup urine disease treatment. Gouyon JB, Desgres J, Mousson C. Pediatr Res; 1994 Mar; 35(3):357-61. PubMed ID: 8190527 [Abstract] [Full Text] [Related] Page: [Next] [New Search]